117 related articles for article (PubMed ID: 1354549)
1. Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease.
Krantic S; Robitaille Y; Quirion R
Brain Res; 1992 Feb; 573(2):299-304. PubMed ID: 1354549
[TBL] [Abstract][Full Text] [Related]
2. Quantitative radioautographic study of somatostatin receptors heterogeneity in the rat extrahypothalamic brain.
Krantic S; Martel JC; Weissmann D; Pujol JF; Quirion R
Neuroscience; 1990; 39(1):127-37. PubMed ID: 1982463
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy.
Epelbaum J; Javoy-Agid F; Enjalbert A; Krantic S; Kordon C; Agid Y
J Neurol Sci; 1988 Nov; 87(2-3):167-74. PubMed ID: 2905385
[TBL] [Abstract][Full Text] [Related]
4. Radioautographic analysis of somatostatin receptor sub-type in rat hypothalamus.
Krantic S; Martel JC; Weissmann D; Quirion R
Brain Res; 1989 Oct; 498(2):267-78. PubMed ID: 2571396
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of somatostatin receptors in the rat cerebellum during development.
Gonzalez BJ; Leroux P; Bodenant C; Braquet P; Vaudry H
J Neurochem; 1990 Sep; 55(3):729-37. PubMed ID: 1974603
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a single class of somatostatin receptors in ground squirrel cerebral cortex.
Krantic S; Petrovic VM; Quirion R; Kordon C
Peptides; 1989; 10(1):57-62. PubMed ID: 2568625
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of [125I]-Tyr0DTrp8-somatostatin binding in sst1- to sst4- and SRIF-gene-invalidated mouse brain.
Videau C; Hochgeschwender U; Kreienkamp HJ; Brennan MB; Viollet C; Richter D; Epelbaum J
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):562-71. PubMed ID: 12759718
[TBL] [Abstract][Full Text] [Related]
8. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
9. 125I-[Tyr0,D-Trp8]somatostatin-14 binding sites in the locus coeruleus of the rat are located on both ascending and descending projecting noradrenergic cells.
Epelbaum J; Bluet-Pajot MT; Llorens-Cortes C; Kordon C; Mounier F; Senut MC; Videau C
Peptides; 1990; 11(1):21-7. PubMed ID: 1971440
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution of somatostatin receptor binding and modulation of adenylyl cyclase activity in Alzheimer's disease brain.
Bergström L; Garlind A; Nilsson L; Alafuzoff I; Fowler CJ; Winblad B; Cowburn RF
J Neurol Sci; 1991 Oct; 105(2):225-33. PubMed ID: 1684616
[TBL] [Abstract][Full Text] [Related]
11. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
Presky DH; Schonbrunn A
Mol Pharmacol; 1988 Nov; 34(5):651-8. PubMed ID: 2904115
[TBL] [Abstract][Full Text] [Related]
12. Purification of a putative brain somatostatin receptor.
He HT; Johnson K; Thermos K; Reisine T
Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1480-4. PubMed ID: 2564203
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin and Alzheimer's disease.
Burgos-Ramos E; Hervás-Aguilar A; Aguado-Llera D; Puebla-Jiménez L; Hernández-Pinto AM; Barrios V; Arilla-Ferreiro E
Mol Cell Endocrinol; 2008 May; 286(1-2):104-11. PubMed ID: 18359553
[TBL] [Abstract][Full Text] [Related]
14. Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
Whitford C; Candy J; Edwardson J; Perry R
J Neurol Sci; 1988 Aug; 86(1):13-8. PubMed ID: 2902199
[TBL] [Abstract][Full Text] [Related]
15. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Tran VT; Chattha G; Bird ED; Martin JB
Science; 1985 Jul; 229(4710):289-91. PubMed ID: 2861661
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptors and somatostatin content in medullary thyroid carcinomas.
Reubi JC; Chayvialle JA; Franc B; Cohen R; Calmettes C; Modigliani E
Lab Invest; 1991 Apr; 64(4):567-73. PubMed ID: 1673164
[TBL] [Abstract][Full Text] [Related]
17. Regional distribution of somatostatin receptor affinity states in rat brain: effects of divalent cations and GTP.
Moyse E; Slama A; Videau C; de Angela P; Kordon C; Epelbaum J
Regul Pept; 1989 Dec; 26(3):225-34. PubMed ID: 2576146
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptors in the human cerebellum during development.
Laquerrière A; Leroux P; Gonzalez B; Bodenant C; Tayot J; Vaudry H
Brain Res; 1992 Feb; 573(2):251-9. PubMed ID: 1354548
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer's disease.
Martel JC; Alagar R; Robitaille Y; Quirion R
Brain Res; 1990 Jun; 519(1-2):228-35. PubMed ID: 2168782
[TBL] [Abstract][Full Text] [Related]
20. Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis.
Heiman ML; Murphy WA; Coy DH
Neuroendocrinology; 1987 Jun; 45(6):429-36. PubMed ID: 2886933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
